Virax Biolabs (VRAX) Liabilities and Shareholders Equity (2021 - 2026)
Virax Biolabs (VRAX) reported Liabilities and Shareholders Equity of $8.32 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), up 29.5% from $6.43 million a year earlier.
Powered by 
Analysis
Virax Biolabs (VRAX) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Dating back to fiscal Q4 2021, Virax Biolabs' Liabilities and Shareholders Equity record includes 10 quarters.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 191.4% (FY2021 to FY2026).
- By fiscal year, Liabilities and Shareholders Equity came in at $6.43 million in FY2025 (+17.2%), $5.48 million in FY2024 (-44.1%), $9.81 million in FY2023 and $48,706 in FY2022 (+22.9%).
- The fiscal Q4 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity since fiscal Q2 2025.
- Year over year, Liabilities and Shareholders Equity gained in three of the last four quarters, with growth averaging 10.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 20.88 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 13.87 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 50.73 Bn |
| 10 | Virax Biolabs | 866,746.23 | -20.67 Mn | - | 8.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 8.32 Mn |
| Sep 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 6.43 Mn |
| Sep 30, 2024 | 9.44 Mn |
| Mar 31, 2024 | 5.48 Mn |
| Sep 30, 2023 | 7.03 Mn |
| Mar 31, 2023 | 9.81 Mn |
| Sep 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 48,706.00 |
| Mar 31, 2021 | 39,621.00 |
API Access
Virax Biolabs Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "VRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();